Latest News and Press Releases
Want to stay updated on the latest news?
-
KHANTY-MANSIYSK, Russia, Sept. 20, 2011 (GLOBE NEWSWIRE) -- Russian grandmaster Peter Svidler, 35, captured the World Cup title on Monday after winning a four-game final against his compatriot...
-
HALLOWELL, ME--(Marketwire - Sep 20, 2011) - Granite Hill Estates (GHE), the Kennebec Valley's premiere continuing care retirement community, welcomes Monmouth-based photographer, Chuck Hillier, as...
-
TORONTO, ONTARIO--(Marketwire - Sept. 20, 2011) - Capstone Infrastructure Corporation (TSX:CSE)(TSX:CSE.DB.A)(TSX:CSE.PR.A) (the "Corporation") today declared a dividend on its common...
-
PEABODY, Mass., Sept. 20, 2011 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), a leading provider of medical imaging and aviation security technology, today announced results for its fourth...
-
ROMEOVILLE, Ill., Sept. 20, 2011 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (Nasdaq:NANX), a technology leader in the development of advanced nanoengineered products, announced today that...
-
NEW YORK, Sept. 20, 2011 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) (the "Company") announced today that its Board of Directors declared on September 20, 2011 a cash dividend of...
-
RICHARDSON, Texas, Sept. 20, 2011 (GLOBE NEWSWIRE) -- Corporate strategist Dan Burrus, author of Flash Foresight, will talk to C-suite officers and corporate board members about their rapidly changing...
-
SANDPOINT, Idaho, Sept. 20, 2011 (GLOBE NEWSWIRE) -- Coldwater Creek Inc. (Nasdaq:CWTR) today announced that Claudia Runkel will join the Company on October 3, 2011 as Senior Vice President of...
-
HUNTINGTON BEACH, Calif., Sept. 20, 2011 (GLOBE NEWSWIRE) -- BJ's Restaurants, Inc. (Nasdaq:BJRI) today announced the opening of its newest restaurant in Pembroke Pines, Florida on September 19, 2011....
-
THE WOODLANDS, Texas, Sept. 20, 2011 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced it has commenced the dosing of the final cohort in its Phase 2 low-dose trial of...